Literature DB >> 12919753

Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood.

Inna G Ovsyannikova1, Kenneth L Johnson, Stephen Naylor, David C Muddiman, Gregory A Poland.   

Abstract

This is the first report of the direct identification of a HLA-DRB1*03 measles-derived peptide from measles virus infected EBV-transformed B cells. We purified HLA-DR3-peptide complexes from EBV-B cells infected with measles virus (Edmonston strain) and sequenced the HLA-DR3-peptides by mass spectrometry. A class II peptide, derived from a measles phosphoprotein, ASDVETAEGGEIHELLRLQ (P1, residues 179-197), exhibited the capacity to stimulate peripheral blood mononuclear cells to proliferate. Our data provides direct evidence that the antigenic peptide of measles virus was processed by antigen-presenting cells, presented in the context of HLA class II molecules, and was recognized by peripheral blood T cells from healthy individuals previously immunized with measles vaccine. The approach described herein provides a useful methodology for the future identification of HLA-presented pathogen-derived epitopes using mass spectrometry. The study of cell-mediated immune responses to the measles-derived peptide in immune persons should provide significant insight into the design and development of new vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919753     DOI: 10.1016/s0042-6822(03)00281-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.

Authors:  Dirk Homann; Hanna Lewicki; David Brooks; Jens Eberlein; Valerie Mallet-Designé; Luc Teyton; Michael B A Oldstone
Journal:  Virology       Date:  2007-02-21       Impact factor: 3.616

Review 2.  Vaccinomics: current findings, challenges and novel approaches for vaccine development.

Authors:  Inna G Ovsyannikova; Gregory A Poland
Journal:  AAPS J       Date:  2011-06-14       Impact factor: 4.009

Review 3.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

4.  Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus.

Authors:  Kenneth L Johnson; Inna G Ovsyannikova; Benjamin J Madden; Gregory A Poland; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2005-09-26       Impact factor: 3.109

5.  Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.

Authors:  Inna G Ovsyannikova; Robert A Vierkant; Gregory A Poland
Journal:  Vaccine       Date:  2006-05-03       Impact factor: 3.641

6.  Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.

Authors:  Inna G Ovsyannikova; Kenneth L Johnson; David C Muddiman; Robert A Vierkant; Gregory A Poland
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor.

Authors:  Iwona Strug; J Mauricio Calvo-Calle; Karin M Green; John Cruz; Francis A Ennis; James E Evans; Lawrence J Stern
Journal:  J Proteome Res       Date:  2008-05-29       Impact factor: 4.466

Review 8.  Variability in Humoral Immunity to Measles Vaccine: New Developments.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Jennifer A Whitaker; Gregory A Poland
Journal:  Trends Mol Med       Date:  2015-11-18       Impact factor: 11.951

9.  HLA-DR specific monoclonal antibodies block lymphoproliferative response to measles vaccine in vitro: a pilot study.

Authors:  David M Phelan; Gregory A Poland
Journal:  Vaccine       Date:  2012-08-31       Impact factor: 3.641

10.  Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals.

Authors:  Inna G Ovsyannikova; Gregory A Poland; Nathan J Easler; Robert A Vierkant
Journal:  Hum Immunol       Date:  2004-03       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.